Navigation Links
BioSpain 2014 Expands its Investment Forum Through Wider Range of Investor Profiles and more Participating Companies
Date:7/16/2014

MADRID, July 16, 2014 /PRNewswire/ --


Biospain 2014 is currently seeking and selecting projects for presentation as part of its Investment Forum, one of the most high profile in the sector, for which 25 investment funds - 70% of which are international- have already confirmed their attendance, a figure the organisers expect to double.

     (Logo: http://photos.prnewswire.com/prnh/20140716/697032)

This year the Forum will be bolstered by the presence of a wider range of investor profiles, a bigger international presence and more participating companies.  

There are currently 10 available slots for companies and other entities wishing to pitch a business plan to the attending investors. In total, there will be 40 presentations over the three day duration of Biospain, each lasting 8-10 minutes, with alternating conferences on a wide range of investment issues (including corporate funds for big pharma, large international funds, PPP initiatives, business angels, industrial capital from non-pharma sectors and crowdfunding, to name a few).    

Among the most important funds to attend Biospain feature companies such as Aravis Ventures (Switzerland), Caixa Capital Risc (Spain), Cross Road Biotech (Spain), Edmond de Rothschild Investment  Partners (France), Forbion Capital Partners (Netherlands), Index Ventures (Switzerland), Johnson & Johnson Development Corporation (UK), LG Life Sciences (South Korea), Merck Serono Ventures (Germany), Novartis Venture Fund (Switzerland), Sofinnova Partners (France), Takeda Ventures (US), Ysios Capital Partners (Spain), Glaxo SmithKline Pharmaceuticals (UK) y Warburg Pincus (UK).

BioSpain 2014 (http://www.biospain2014.org), the 7th International Biotechnology Conference, is a biennial event which will take place from the 24th to the 26th of September in the Palacio de Congresos y Exposiciones de Galicia (Galicia Conference Centre), Santiago de Compostela (A Coruña). It is organised by the Spanish Bioindustry Association (ASEBIO) and on this edition, also by the Autonomous Government of Galicia, the University of santiago de Compostela, the University of Vigo and Santiago City Council.

Stand space at the trade fair is experiencing high demand, with 80% already allocated to exhibitors.  

So far we can confirm the attendance of over 100 companies and other entities from 20 countries, including delegations from countries such as PortugalCanadaColombiaMexicoRussia, the UK and India. Biospain expects to attract 2000 participants - 10% more than in 2012 - exceeding the benchmark set that year of 800 companies and institutions from 40 countries.

BioSpain 2014 is sponsored by Bioibérica, Merck, MSD, Zeltia Group, Roche Institute and CLAMBER (Castilla La Mancha Bioeconomy Region).

Lucía Cecilia
Head of Communications for BioSpain 2014 and ASEBIO
landline. + 34-912109374/10
mobile: + 34-663 117-293    
e-mail: lcecilia@asebio.com / lcecilia@biospain2014.org



'/>"/>
SOURCE ASEBIO (Spanish Bioindustry Association)
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpain 2014 erweitert ihr Investoren-Forum durch breiter gestreute Investorenprofile und mehr teilnehmende Unternehmen
2. BioSpain 2014 amplia il proprio Investment Forum attraverso una più ricca gamma di profili di investitori e un maggior numero di aziende partecipanti
3. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
4. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
5. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
6. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. PRA Expands Operations in Europe
9. USANA Health Sciences Expands Award-Winning Research and Development Team
10. Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films
11. Argus Expands Specialty Pharmacy with Amber Pharmacy Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
(Date:10/2/2017)... PHILADELPHIA , Oct. 2, 2017 Halo Labs announces ... particle analysis system called the HORIZON at MIBio 2017 in ... analyzes subvisible and visible particulate matter in biopharmaceutical samples with unprecedented ... use of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The ... to promote standards of excellence for the field of eating disorders, announces the ... – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
Breaking Medicine News(10 mins):